台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    59.3
  • 漲跌
    ▼0.5
  • 漲幅
    -0.84%
  • 成交量
    24
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
東生華 (8432)籌碼相關-群益金鼎-西松 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-西松 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1600.00158.6058.40-184-1.18%
2025/01/1300.00259.5059.00-288-2.27%
2025/01/08261.3000.0061.302942.12%
2025/01/06561.2600.0061.2051044.80%
2024/11/2200.00164.2064.40-1148-0.67%
2024/11/20164.0000.0063.8011480.67%
2024/11/1200.00263.5063.40-2137-1.45%
2024/11/080.365.0000.0065.700.31320.23%
2024/08/091456.531456.7156.2002030.00%
2024/07/30464.18464.6566.2002310.00%
2024/07/10161.20261.2561.40-1233-0.43%
2024/07/09462.63362.0361.5012320.43%
2024/07/0400.00169.4067.80-1223-0.45%
2024/07/03269.05169.0068.9012250.44%
2024/07/0200.00169.4069.20-1226-0.44%
2024/07/01369.00269.9068.5012260.44%
2024/06/2800.00169.3069.70-1229-0.44%
2024/06/27168.2000.0068.8012310.43%
2024/06/13163.90164.3064.0002190.00%
2024/06/12765.07765.0764.2002200.00%
2024/06/07166.30166.4066.3002170.00%
2024/06/0500.00163.6064.00-1212-0.47%
2024/06/04263.85164.0063.3012140.47%
2024/05/2800.00361.9361.90-3244-1.23%
2024/05/2700.00362.1061.80-3251-1.19%
2024/05/2400.00462.3062.30-4268-1.49%
2024/05/231163.04165.3062.50102693.71%
2024/05/21266.65266.4566.3002890.00%
2024/05/2000.00167.4067.90-1307-0.32%
2024/05/17167.5000.0066.1013060.33%
2024/05/16264.80265.9565.9003070.00%
2024/05/1400.00165.6065.60-1323-0.31%
2024/05/13165.20165.7064.3003220.00%
2024/05/03159.70159.6059.5002690.00%
2024/04/29160.20160.3060.3002640.00%
2024/04/25258.25258.6059.0002580.00%
2024/04/24759.13759.3359.5002570.00%
2024/04/2300.00160.5060.70-1255-0.39%
2024/04/15256.35256.4555.9002590.00%
2024/04/09358.47358.2057.7002580.00%
2024/04/0100.00157.8058.20-1250-0.40%
2024/03/29257.35157.5057.2012540.39%
2024/03/2700.00156.8058.30-1254-0.39%
2024/03/26256.8000.0056.4022520.79%
2024/03/2000.00155.4055.40-1249-0.40%
2024/03/18154.2000.0054.2012500.40%
2024/03/14256.30256.6056.8002470.00%
2024/03/13157.4000.0056.8012460.40%
2024/03/12155.90257.2558.10-1246-0.41%
2024/03/1100.00356.7756.10-3246-1.22%
2024/03/08655.58256.7056.0042461.62%
2024/03/06357.20458.3358.00-1238-0.42%
2024/03/0500.00261.4561.20-2228-0.88%
2024/03/04463.70263.0561.1022260.88%
2024/02/29862.83862.3163.6002200.00%
2024/02/23162.9010.262.6061.00-9.2202-4.56%
2024/02/22961.30960.7660.0001930.00%
2024/02/191057.0500.0056.00101616.18%
2024/02/1500.001154.5054.50-11149-7.35%
2024/02/021149.5800.0049.40111736.33%
東生華加速16項新品專案開發 目標未來5年營收翻倍Anue鉅亨-2024/12/20
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華 相關文章